Pharma Packaging

Pharma Packaging Compliance Services

Supporting pharma primary packaging manufacturers with ISO 15378 cGMP, US FDA Type III DMF filings, and pharmacopoeia testing coordination.

  • Market route first
  • Evidence files aligned
  • Less rework before audits
Core Challenges

Pharma Packaging & Material Challenges

Primary packaging contacts the formulation directly; its quality impacts drug safety, requiring strict inertness testing and contamination controls.

ISO 15378 cGMP Compliance

Pharma buyers require packaging manufacture under cleanroom controls (Grade D or above) and packaging cGMP.

Extractables & Leachables (E&L)

Manufacturers must evaluate compatibility and E&L (Extractables & Leachables) data over long-term storage.

FDA Type III DMF Filing

For U.S. access, drug developers reference the packaging supplier’s Type III DMF (Packaging Master File).

Pharmacopoeia Chemical Tests

Plastic bottles, glass vials, and rubber stoppers must pass USP <661> (plastics) and USP <381> (rubber) tests.

Solutions

Related Compliance Support

QTC supports pharmaceutical packaging sites with cGMP control evidence for direct-contact materials, technical files, and compatibility, integrity, and material testing coordination.

ISO 15378 cGMP System Setup & Certification Coaching

8-16 weeks

For: Primary packaging sites (vials, rubber stoppers, blister packs) seeking ISO 15378 certification.

Key Goal

Goal: Establish a compliant packaging QMS to pass third-party audits and secure certification

What you get
  • Gap report on site cleanliness, HVAC, pest control, and mix-ups aligned with ISO 15378
  • Compilation of quality control, release, traceability, and cleanroom SOPs
  • Pre-audit mock exercises for Stage 1 (dossier review) and Stage 2 (on-site audit)
  • CAPA remediation tracking and nonconformity closure support

US FDA Type III DMF (Pharma Packaging) Submission

6-10 weeks

For: Packaging suppliers exporting to the U.S. who need to provide DMF authorization for their customers.

Key Goal

Goal: Submit and activate the Type III DMF to provide regulatory clearance for drug developers

What you get
  • Technical review of material formulation (composition, additives), physical specs, and stability data
  • Compilation of complete CTD-formatted Type III DMF (Packaging Master File) per FDA standards
  • Facilitate FDA submission to obtain a DMF number and Letter of Authorization (LOA)
  • Coaching for responding to regulatory packaging deficiency letters

Pharma Packaging Extractables & Leachables (E&L) Study Design & Review

4-8 weeks

For: Packaging suppliers already committed to E&L test programs or facing customer demands for ADE/PDE safety assessments.

Key Goal

Goal: Establish packaging safety data foundation to pass customer verification or integrate into DMF filing

What you get
  • Chemical characterization study design per ISO 10993-18 for container-closure systems
  • Simulated extraction and leachables test plan design with ISO 17025 lab coordination
  • Leachable safety assessment and Threshold of Toxicological Concern (TTC) per ICH Q3B/PQRI
  • Review and standardize packaging E&L documentation for regulatory submission

Container Closure Integrity Testing (CCIT) Plan Design & Review

3-6 weeks

For: Sterile packaging suppliers completing USP <1207>-compliant CCIT validation or facing customer integrity audit requests.

Key Goal

Goal: Establish a validated CCIT documentation package for DMF integration or international customer audits

What you get
  • CCIT method selection and study plan per USP <1207> / ASTM F2338
  • Recommendations for applicable CCIT technologies (HeLI, pressure decay, headspace analysis) and validation report templates
  • Test equipment selection and lab sourcing recommendations
  • Review of existing CCIT SOPs and compliance recommendations for each phase
Regulatory References

Packaging Standards & Tests

Primary packaging materials must conform to these globally accepted standards and USP chapters.

ISO 15378

Quality management system standard for primary packaging materials, combining ISO 9001 and cGMP.

USP <661.1> / <661.2>

USP chapters regulating characterization and testing of plastic packaging materials.

USP <381>

USP chapter regulating physicochemical tests for elastomeric closures used in injections.

Type III DMF

Packaging Master File submitted to FDA, referenced by downstream drug applications.

FAQ

Frequently Asked Questions

Answering core queries for packaging suppliers on DMF filing and GxP audits.

Sustainability & ESG

Do Your Buyers Also Request ESG Evidence?

Pharma brands and manufacturers increasingly face social audits (EcoVadis, CDP, carbon footprints, human rights) alongside standard GxP/cGMP quality requirements.

Ready to Draft a Packaging DMF or Schedule an ISO 15378 Pre-audit?

Share your packaging type (glass/plastic/rubber/foil), direct-contact status, target market, and quality manual. QTC experts will design a QMS or DMF plan.

Contact QTC